• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从研究用微流控平台到自动化流体仪器,即 VTX-1 液体活检系统:快速且无需标记的血液中循环肿瘤细胞分离。

Fast and Label-Free Isolation of Circulating Tumor Cells from Blood: From a Research Microfluidic Platform to an Automated Fluidic Instrument, VTX-1 Liquid Biopsy System.

机构信息

1 Vortex Biosciences Inc., Menlo Park, CA, USA.

2 Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

SLAS Technol. 2018 Feb;23(1):16-29. doi: 10.1177/2472630317738698.

DOI:10.1177/2472630317738698
PMID:29355087
Abstract

Tumor tissue biopsies are invasive, costly, and collect a limited cell population not completely reflective of patient cancer cell diversity. Circulating tumor cells (CTCs) can be isolated from a simple blood draw and may be representative of the diverse biology from multiple tumor sites. The VTX-1 Liquid Biopsy System was designed to automate the isolation of clinically relevant CTC populations, making the CTCs available for easy analysis. We present here the transition from a cutting-edge microfluidic innovation in the lab to a commercial, automated system for isolating CTCs directly from whole blood. As the technology evolved into a commercial system, flexible polydimethylsiloxane microfluidic chips were replaced by rigid poly(methyl methacrylate) chips for a 2.2-fold increase in cell recovery. Automating the fluidic processing with the VTX-1 further improved cancer cell recovery by nearly 1.4-fold, with a 2.8-fold decrease in contaminating white blood cells and overall improved reproducibility. Two isolation protocols were optimized that favor either the cancer cell recovery (up to 71.6% recovery) or sample purity (≤100 white blood cells/mL). The VTX-1's performance was further tested with three different spiked breast or lung cancer cell lines, with 69.0% to 79.5% cell recovery. Finally, several cancer research applications are presented using the commercial VTX-1 system.

摘要

肿瘤组织活检具有侵袭性、费用高,且只能采集有限的细胞群体,无法完全反映患者癌细胞的多样性。循环肿瘤细胞 (CTC) 可从简单的血液采集分离出来,并且可能代表来自多个肿瘤部位的多样化生物学特性。VTX-1 液体活检系统旨在自动分离具有临床相关性的 CTC 群体,使 CTC 易于分析。本研究介绍了从实验室的尖端微流控创新到直接从全血中分离 CTC 的商业化、自动化系统的转变。随着该技术演变为商业系统,灵活的聚二甲基硅氧烷微流控芯片被刚性的聚甲基丙烯酸甲酯芯片所取代,细胞回收率提高了 2.2 倍。VTX-1 自动进行流体处理,使癌细胞回收率进一步提高了近 1.4 倍,白细胞污染减少了 2.8 倍,整体重现性得到提高。优化了两种分离方案,一种有利于癌细胞回收率(高达 71.6%的回收率),另一种有利于样品纯度(≤100 个白细胞/mL)。使用三种不同的乳腺癌或肺癌细胞系对 VTX-1 的性能进行了进一步测试,细胞回收率为 69.0%至 79.5%。最后,使用商业 VTX-1 系统介绍了几种癌症研究应用。

相似文献

1
Fast and Label-Free Isolation of Circulating Tumor Cells from Blood: From a Research Microfluidic Platform to an Automated Fluidic Instrument, VTX-1 Liquid Biopsy System.从研究用微流控平台到自动化流体仪器,即 VTX-1 液体活检系统:快速且无需标记的血液中循环肿瘤细胞分离。
SLAS Technol. 2018 Feb;23(1):16-29. doi: 10.1177/2472630317738698.
2
VTX-1 Liquid Biopsy System for Fully-Automated and Label-Free Isolation of Circulating Tumor Cells with Automated Enumeration by BioView Platform.VTX-1 液体活检系统,用于通过 BioView 平台全自动、无标记地分离循环肿瘤细胞,并自动计数。
Cytometry A. 2018 Dec;93(12):1240-1245. doi: 10.1002/cyto.a.23592. Epub 2018 Sep 13.
3
[Recent advances in isolation and detection of circulating tumor cells with a microfluidic system].[微流控系统在循环肿瘤细胞分离与检测方面的最新进展]
Se Pu. 2022 Mar 8;40(3):213-223. doi: 10.3724/SP.J.1123.2021.07009.
4
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells.临床微流控芯片平台用于多种循环肿瘤细胞的分离。
J Vis Exp. 2023 Oct 13(200). doi: 10.3791/64674.
5
Integrated Microfluidic Device for Enrichment and Identification of Circulating Tumor Cells from the Blood of Patients with Colorectal Cancer.集成微流控芯片从结直肠癌患者血液中富集和鉴定循环肿瘤细胞。
Dis Markers. 2019 Jul 1;2019:8945974. doi: 10.1155/2019/8945974. eCollection 2019.
6
Microfluidic-Based Technologies for CTC Isolation: A Review of 10 Years of Intense Efforts towards Liquid Biopsy.基于微流控技术的循环肿瘤细胞分离:液体活检十年来的努力综述。
Int J Mol Sci. 2022 Feb 10;23(4):1981. doi: 10.3390/ijms23041981.
7
A high-throughput liquid biopsy for rapid rare cell separation from large-volume samples.一种高通量液体活检技术,可从大体积样本中快速分离稀有细胞。
Lab Chip. 2018 Dec 18;19(1):68-78. doi: 10.1039/c8lc01048j.
8
Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients.快速高效的微流控细胞过滤器,用于从结直肠癌患者未经处理的全血中分离循环肿瘤细胞。
Sci Rep. 2019 May 29;9(1):8032. doi: 10.1038/s41598-019-44401-1.
9
Combination of microfluidic chips and biosensing for the enrichment of circulating tumor cells.微流控芯片与生物传感联合用于循环肿瘤细胞的富集。
Biosens Bioelectron. 2022 Apr 15;202:114025. doi: 10.1016/j.bios.2022.114025. Epub 2022 Jan 20.
10
Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer.用于循环肿瘤细胞分离的楔形微流控芯片及其在胃癌中的临床意义。
J Transl Med. 2018 May 23;16(1):139. doi: 10.1186/s12967-018-1521-8.

引用本文的文献

1
Precision Oncology Framework Using Circulating Tumor Cells.使用循环肿瘤细胞的精准肿瘤学框架
Int J Mol Sci. 2025 Jun 10;26(12):5539. doi: 10.3390/ijms26125539.
2
Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer.循环肿瘤细胞检测在乳腺癌治疗和预后中的作用
Cancer Med. 2025 Jun;14(11):e70902. doi: 10.1002/cam4.70902.
3
Advances in circulating tumor cells for early detection, prognosis and metastasis reduction in lung cancer.循环肿瘤细胞在肺癌早期检测、预后评估及减少转移方面的进展
Front Oncol. 2024 Jun 21;14:1411731. doi: 10.3389/fonc.2024.1411731. eCollection 2024.
4
Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest.通过将 VTX-1 CTC 分离系统与 QIAGEN AdnaTest 相结合,检测转移性去势抵抗性前列腺癌(mCRPC)患者的循环肿瘤细胞(CTC)和血浆外泌体衍生 cfRNA 中的雄激素受体(AR)、AR 变体 7(AR-V7)、前列腺特异性膜抗原(PSMA)和前列腺特异性抗原(PSA)基因表达。
BMC Cancer. 2024 Apr 16;24(1):482. doi: 10.1186/s12885-024-12139-3.
5
Vortex sorting of rare particles/cells in microcavities: A review.微腔中稀有颗粒/细胞的涡旋分选:综述
Biomicrofluidics. 2024 Apr 1;18(2):021504. doi: 10.1063/5.0174938. eCollection 2024 Mar.
6
Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters.使用循环肿瘤细胞(CTC)数量与其他临床参数的联合分析在增强癌症诊断、预后评估和监测方面的最新进展
Cancers (Basel). 2023 Nov 11;15(22):5372. doi: 10.3390/cancers15225372.
7
High-Efficiency Inertial Separation of Microparticles Using Elevated Columned Reservoirs and Vortex Technique for Lab-on-a-Chip Applications.使用升高的柱状储液器和涡旋技术对微颗粒进行高效惯性分离,用于芯片实验室应用。
ACS Omega. 2023 Jul 25;8(31):28628-28639. doi: 10.1021/acsomega.3c03136. eCollection 2023 Aug 8.
8
Recent Advances in Methods for Circulating Tumor Cell Detection.循环肿瘤细胞检测方法的最新进展。
Int J Mol Sci. 2023 Feb 15;24(4):3902. doi: 10.3390/ijms24043902.
9
Circulating tumor cell isolation for cancer diagnosis and prognosis.循环肿瘤细胞分离用于癌症诊断和预后。
EBioMedicine. 2022 Sep;83:104237. doi: 10.1016/j.ebiom.2022.104237. Epub 2022 Aug 27.
10
From Exosomes to Circulating Tumor Cells: Using Microfluidics to Detect High Predictive Cancer Biomarkers.从外泌体到循环肿瘤细胞:利用微流控技术检测高预测性癌症生物标志物。
Adv Exp Med Biol. 2022;1379:369-387. doi: 10.1007/978-3-031-04039-9_15.